For example, CD19+CD5+ cells isolated from the peripheral blood of ibrutinib-treated MCL patients had a significant reduction in CXCR4, CD38 markers, and chemokine expression associated with adhesion and chemotaxis of MCL cells [10]. The gene discussed is CD19; the disease is mantle cell lymphoma.